147 related articles for article (PubMed ID: 29089306)
1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.
Ellawatty WEA; Masuo Y; Fujita KI; Yamazaki E; Ishida H; Arakawa H; Nakamichi N; Abdelwahed R; Sasaki Y; Kato Y
Drug Metab Dispos; 2018 Jan; 46(1):33-40. PubMed ID: 29089306
[TBL] [Abstract][Full Text] [Related]
2. Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A.
Panfen E; Chen W; Zhang Y; Sinz M; Marathe P; Gan J; Shen H
Drug Metab Dispos; 2019 Nov; 47(11):1352-1360. PubMed ID: 31427432
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
4. Short-lasting inhibition of hepatic uptake transporter OATP1B1 by tyrosine kinase inhibitor pazopanib.
Taguchi T; Masuo Y; Sakai Y; Kato Y
Drug Metab Pharmacokinet; 2019 Dec; 34(6):372-379. PubMed ID: 31703927
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity.
Morse BL; Fallon JK; Kolur A; Hogan AT; Smith PC; Hillgren KM
AAPS J; 2021 Apr; 23(3):58. PubMed ID: 33903987
[TBL] [Abstract][Full Text] [Related]
6. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
Iwase M; Fujita KI; Nishimura Y; Seba N; Masuo Y; Ishida H; Kato Y; Kiuchi Y
Cancer Chemother Pharmacol; 2019 May; 83(5):993-998. PubMed ID: 30810774
[TBL] [Abstract][Full Text] [Related]
7. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1.
Li L; Lei H; Wang W; Du W; Yuan J; Tu M; Zhou H; Zeng S; Jiang H
Biopharm Drug Dispos; 2018 Nov; 39(9):411-419. PubMed ID: 30294927
[TBL] [Abstract][Full Text] [Related]
9. Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1.
Higgins JW; Ke AB; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2014 Nov; 42(11):1780-4. PubMed ID: 25106415
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
[TBL] [Abstract][Full Text] [Related]
11. OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
Matthaei J; Kuron D; Faltraco F; Knoch T; Dos Santos Pereira JN; Abu Abed M; Prukop T; Brockmöller J; Tzvetkov MV
Clin Pharmacol Ther; 2016 Jun; 99(6):633-41. PubMed ID: 26659468
[TBL] [Abstract][Full Text] [Related]
12. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
[TBL] [Abstract][Full Text] [Related]
13. Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations.
Meyer MJ; Tuerkova A; Römer S; Wenzel C; Seitz T; Gaedcke J; Oswald S; Brockmöller J; Zdrazil B; Tzvetkov MV
Drug Metab Dispos; 2020 Dec; 48(12):1380-1392. PubMed ID: 33037045
[TBL] [Abstract][Full Text] [Related]
14. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA
Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690
[TBL] [Abstract][Full Text] [Related]
15. Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans.
Liao M; Zhu Q; Zhu A; Gemski C; Ma B; Guan E; Li AP; Xiao G; Xia CQ
Xenobiotica; 2019 Jul; 49(7):852-862. PubMed ID: 30132394
[TBL] [Abstract][Full Text] [Related]
16. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
17. Involvement of organic cation transporters in the clearance and milk secretion of thiamine in mice.
Kato K; Moriyama C; Ito N; Zhang X; Hachiuma K; Hagima N; Iwata K; Yamaguchi J; Maeda K; Ito K; Suzuki H; Sugiyama Y; Kusuhara H
Pharm Res; 2015 Jul; 32(7):2192-204. PubMed ID: 25701312
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide.
Miyake T; Mizuno T; Mochizuki T; Kimura M; Matsuki S; Irie S; Ieiri I; Maeda K; Kusuhara H
J Pharm Sci; 2017 Sep; 106(9):2542-2550. PubMed ID: 28479364
[TBL] [Abstract][Full Text] [Related]
19. Successful Prediction of Positron Emission Tomography-Imaged Metformin Hepatic Uptake Clearance in Humans Using the Quantitative Proteomics-Informed Relative Expression Factor Approach.
Sachar M; Kumar V; Gormsen LC; Munk OL; Unadkat JD
Drug Metab Dispos; 2020 Nov; 48(11):1210-1216. PubMed ID: 32843330
[TBL] [Abstract][Full Text] [Related]
20. Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity.
Tu M; Li L; Lei H; Ma Z; Chen Z; Sun S; Xu S; Zhou H; Zeng S; Jiang H
Toxicology; 2014 Aug; 322():34-42. PubMed ID: 24799337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
